An immune and cancer cell-targeting antibody therapy has shown potential to eradicate residual traces of deadly blood cell ...

A friend just underwent a rotator cuff repair and is recovering well. But I was wondering, what if you get to a point where ...

All three dose groups (50 mg, 100 mg and 200 mg) showed impressive monotherapy efficacy, with VGPR+ (very good partial response or better) of ...

Gintemetostat showed promising activity in heavily pretreated, triple-class refractory multiple myeloma, including high-risk t(4;14) patients. The phase 1 study reported a tolerable safety profile, ...

A TEEN saved his own life when he ignored his GP and used ChatGPT to diagnose a rare medical condition. Kahlan Eales, 17, ...

Innovative outcome measures coupled with a focus on patient-centered clinical differentiation can help the biopharma industry ...

Orna Therapeutics (Orna), a biotechnology company dedicated to engineering immune cells in vivo to treat autoimmune and oncology diseases, today announced new preclinical data supporting the Company's ...

New research suggests that a severe and specific form of depression involves a systemic disruption linking the immune system ...

December 7, 2025 - By Will Houston - Strong social relationships, particularly emotionally supportive marriages, may help ...

ASH 2025 research shows cancer can arise not just from mutations but from broken DNA architecture. AI reveals how lost genome loops silence tumor suppressor genes.

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and ...

In addition to meeting the primary endpoint of non-inferiority for overall response rate (ORR) in the BRUIN CLL-314 study, pirtobrutinib achieved a numerically higher ORR of 87.0% compared to 78.5% ...